Insider Stock Trading History of Coleman Lewis W


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Coleman Lewis W since year 2005. The trader's CIK number is 1216504. At the time of this reporting, Coleman Lewis W is the Director of Immune Design Corp. . (stock ticker symbol IMDZ). See this page for all insider trading activities at Immune Design Corp. .

Note that in the past COLEMAN LEWIS W also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Coleman Lewis W since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-02 IMDZ Immune Design Corp. Buy 50,000 4.50 225,000
2017-10-27 IMDZ Immune Design Corp. Buy 65,000 4.07 264,745
2017-07-10 IMDZ Immune Design Corp. Buy 10,000 8.99 89,949
2017-07-11 IMDZ Immune Design Corp. Buy 2,000 9.32 18,650
2017-07-06 IMDZ Immune Design Corp. Buy 4,000 9.39 37,552
2017-07-07 IMDZ Immune Design Corp. Buy 4,000 9.15 36,600
2016-12-22 IMDZ Immune Design Corp. Sale 10,000 6.20 62,040
2016-09-20 IMDZ Immune Design Corp. Buy 40,000 6.25 250,000
2015-08-25 IMDZ Immune Design Corp. Buy 3,000 14.50 43,500
2015-04-21 IMDZ Immune Design Corp. Buy 10,000 26.50 265,000
2012-11-07 DWA Dreamworks Animation Skg, Inc. Sale 21,875 20.47 447,803
2011-05-04 NOC Northrop Grumman Corp /de/ Option Ex 11,485 46.74 536,762
2011-05-04 NOC Northrop Grumman Corp /de/ Sale 16,579 64.84 1,074,932
2010-11-09 DWA Dreamworks Animation Skg, Inc. Sale 47,338 34.19 1,618,675
2010-05-06 NOC Northrop Grumman Corp /de/ Sale 2,880 66.52 191,574
2008-04-29 NOC Northrop Grumman Corp /de/ Option Ex 4,500 50.08 225,373
2008-04-29 NOC Northrop Grumman Corp /de/ Sale 4,500 74.30 334,363
2004-10-28 DWA Dreamworks Animation Skg, Inc. Buy 20,000 28.00 560,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Coleman Lewis W (Director of Immune Design Corp. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.